¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"After Burn Double Strength Spray"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • scalding burn
    ¿­ÅÁÈ­»ó
  • steam burn
    Áõ±âÈ­»ó
  • strength
    1. ¼¼±â, °­µµ 2. Èû
  • strength duration curve
    °­µµ±â°£°î¼±
  • shearing strength
    Àü´Ü°­µµ, ¾ù°¥¸²¼¼±â
  • tearing strength
    Âõ±è°­µµ, Àο­°­µµ
  • ultimate strength
    ±ØÇѼ¼±â, ±ØÇѰ­µµ
  • wound strength
    â»ó°­µµ
  • wet strength
    ½ÀÀ±ÀÎÀå°­µµ
  • yield strength
    Ç׺¹°­µµ, Ç׺¹¼¼±â
  • anti-double stranded deoxyribonucleic acid antibody
    Ç×ÀÌÁß°¡´ÚDNAÇ×ü
  • double arcuate scotoma
    ÀÌÁßȰ¾ÏÁ¡
  • double balloon
    ÀÌÁßdz¼±
  • double bind
    ÀÌÁß°á¹Ú, ÀÌÁß°á¼Ó
  • double bladder
    Áߺ¹¹æ±¤
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • bending strength
    ±ÁÈû¼¼±â, ±¼°î°­µµ
  • bonding strength
    °áÇÕÈû
  • strength duration curve
    °­µµ±â°£°î¼±
  • dynamic strength
    µ¿Àû±Ù·Â
  • ego strength
    ÀÚ¾ÆÈû
  • field strength
    ÀÚÀå¼¼±â
  • fringe magnetic field strength
    ÁÖº¯ÀÚÀå¼¼±â, °¡ÀåÀÚ¸®ÀÚÀå¼¼±â
  • grasp strength
    Áã´ÂÈû
  • ionic strength
    À̿°­µµ
  • low-ionic-strength salt solution
    ÀúÀ̿°­µµ¿°¿ë¾×
  • magnetic field strength
    ÀÚÀå¼¼±â, ÀڱⰭµµ
  • marginal strength
    °æ°è°­µµ
  • maximum gradient strength
    ÃÖ´ë°æ»ç¼¼±â, ÃÖ´ë±â¿ï±â¼¼±â
  • muscle strength
    ±ÙÀ°Èû, ±Ù·Â
  • peak gradient strength
    ÃÖ°í°æ»ç¼¼±â, ÃÖ°í±â¿ï±â¼¼±â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • after-vision
    ÀÜ»ó½Ã°¢(íÑßÀò±ÊÆ).
  • positive after image
    ¾ç¼ºÀÜ»ó(åÕàõíÑßÀ).
  • positive after potential
    ¾ç¼ºÈÄÀüÀ§(åÕàõý­ï³êÈ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • bonding strength
    °áÇÕ·Â(Ì¿ùêæ³).
  • edge-strength
    ¿¬´Ü°­µµ(æÞӮ˭öô).
  • ego strength
    ÀÚ¾ÆÀÇ Èû
  • field strength
    ÀÚÀå ¼¼±â, ÀÚÀå·Â
  • flexure strength
    ¿ä°î°­µµ(èúÍØË­öô).
  • fracture strength
    ÆÄÀý°­µµ.
  • fracture strength
    ÆÄÀý °­µµ.
  • fringe magnetic field strength
    ÁÖº¯ ÀÚÀå ¼¼±â
  • ionic strength
    À̿°­µµ
  • ionic strength
    À̿°­µµ(Ë­Óø).
  • low-ionic--strength salt solution =LISS
    ÀúÀ̿°­µµ¿°¿ë¾×
  • low-ionic-strength salt solution TEST = LISS test
    ÀúÀ̿°­µµ¿°¿ë¾×
  • magnetic field strength
    ÀÚÀå ¼¼±â, Àڱ⠰­µµ
  • marginal strength
    ¿¬º¯°­µµ(æÞܫ˭öô).
  • maximum gradient strength
    ÃÖ´ë °æ»ç °­µµ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • double strand break
    ½Ö°¡´Ú ²÷±è
  • double-strand
    ½Ö°¡´Ú
  • double transformation
    ÀÌÁß º¯Çü(ì£ñìܨû¡) (ÔÒ) cotransformation
  • double-well technique
    ÀÌÁ¤¼ú(ì£ïÌâú)
  • electric double layer
    Àü±â(ï³Ñ¨)
  • Helmholtz double layer
    Ç︧ȦÃ÷ ÀÌÁßÃþ(ì£ñìöµ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
dpdt double-pole double-throw [switch]
DRID double radial immunodiffusion; double radioisotope derivative
DV dependent variable; diagnostic variable; difference in volume; digital vibration; dilute volume; dis...
DVR digital vascular reactivity; Doctor of Veterinary Radiology; double valve replacement; double ventri...
BDC Bazex-Dupre-Christol [syndrome]; burn-dressing change
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
RMS Respiratory muscle strength
SBS Shear bond strength
ST Strength training
TBS Tensile Bond Strength
TS Tensile strength
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • after-potential
    ÈÄ ÀüÀ§ Çö»ó
    ½ºÆÄÀÌÅ© ÀüÀ§ µÚ¿¡ º¼ ¼ö ÀÖ´Â ÀüÀ§ º¯µ¿ÀÌ´Ù. À½¼º ÈÄ ÀüÀ§¿Í ¾ç¼º ÈÄ ÀüÀ§·Î ³ª´¶´Ù. ÀüÀÚ´Â ¿ªÄ¡ÀÇ »ó½Â, ÈÄÀÚ´Â Çϰ­À» ÀÏÀ¸Å²´Ù.
  • after-sensation
    ÈÄ °¨°¢
    ¿øÀÎÀÌ µÇ¾ú´ø ÀÚ±ØÀÌ Á¦°ÅµÈ ÈÄ¿¡µµ °è¼ÓµÇ´Â Áö°¢.
  • after-vision
    ÀÜ»ó ½Ã°¢
    ÀÚ±ØÀÌ ±×Ä£ ÈÄ¿¡ ³²¾ÆÀÖ´Â ½Ã°¢ÀÇ ÀÜÁ¸.
  • optokinetic after nystagmus
    ½Ã ¿îµ¿ ÈÄ ¾ÈÁø, ½Ã ¿îµ¿¼º ÈÄ ¾ÈÁø
  • positive after potential
    ¾ç¼º ÈÄÀüÀ§
  • soon after birth
    Ãâ»ý Á÷ÈÄ
  • bending strength
    ±¼°î °­µµ, ±ÁÈû °­µµ
    º¸¿¡ »ý±â´Â ÃÖ´ë ±ÁÈû ÀÀ·Â.
  • compressive strength
    ¾ÐÃà °­µµ
    ¾ÐÃà ½ÃÇè¿¡ À־ Àç·á°¡ ÆÄ±«µÇ¾úÀ» ¶§ÀÇ ÇÏÁßÀ», ½ÃÇèÆíÀÇ ÃÖ¼Ò ´Ü¸éÀûÀ¸·Î ³ª´« °ÍÀ¸·Î, Àç·á°¡ ¾ÐÃà·ÂÀ» ¹ÞÀ» ¶§ ÀúÇ×ÇÏ´Â Èû.
  • edge strength
    ¿¬´Ü °­µµ
    ÆÄ¼â·Â¿¡ ´ëÇÑ ÃæÀü¹° º¯¿¬ÀÇ ÀúÇ×·Â.
  • field strength
    ÀÚÀå ¼¼±â, ÀÚÀå·Â
  • fired strength
    ¼Ò¼º °­µµ
  • flexure strength
    ¿ä°î °­µµ
  • fracture strength
    ÆÄÀý °­µµ
  • fringe magnetic field strength
    ÁÖº¯ ÀÚÀå ¼¼±â
  • margin strength
    º¯¿¬ °­µµ
    °­µµ¶õ ¾î¶² ¹°Ã¼¸¦ ÆÄ°ú½Ã۴µ¥ ÇÊ¿äÇÑ ÃÖ´ëÀÇ ÀÀ·ÂÀ¸·Î¼­ Àη¹ÀÌ ÁöÀ۽à marginal ridge ºÎÀ§¿¡ »ç¿ëµÇ´Â Àç·áÀÇ °­µµ¸¦ ¸»ÇÏ´Â °ÍÀ¸·Î º¯¿¬°­µµ°¡ Å« Àç·áÀÎ °æ¿ì¿¡´Â cavo-surface angleÀº µÐ°¢ÀÌ µÇ°í ±× ¹Ý´ëÀÎ °æ¿ì¿¡´Â Á÷°¢¿¡ °¡±õ°Ô Çü¼ºÇØÁØ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
prescribed burn <ecology> The process of burning an area of land in order to kill certain plant species and to favor the growth of others.
(31 Dec 1997)
second degree burn A burn involving the epidermis and dermis and usually forming blisters that may be superficial, or by deep dermal necrosis, followed by epithelial regeneration extending from the skin appendages.
Synonym: partial-thickness burn.
(05 Mar 2000)
slash, burn, and poison Brutal medical slang term for surgery, radiation, and chemotherapy (as approaches to the treatment of cancer).
(12 Dec 1998)
superficial burn A burn involving only the epidermis and causing erythema and oedema without vesiculation.
Synonym: superficial burn.
(05 Mar 2000)
thermal burn A burn caused by heat.
(05 Mar 2000)
third degree burn A burn involving destruction of the entire skin; deep third-degree burns extend into subcutaneous fat, muscle, or bone and often cause much scarring.
Synonym: full-thickness burn.
(05 Mar 2000)
kangri burn carcinoma kang cancer
first degree burn A burn involving only the epidermis and causing erythema and oedema without vesiculation.
Synonym: superficial burn.
(05 Mar 2000)
flash burn A burn due to very brief exposure to intense radiant heat; the typical burn produced by atomic explosion.
(05 Mar 2000)
full-thickness burn A burn involving destruction of the entire skin; deep third-degree burns extend into subcutaneous fat, muscle, or bone and often cause much scarring.
Synonym: full-thickness burn.
(05 Mar 2000)
bufadienolides (two double bonds) Bufatrienolides (three double bonds), etc; they have varying numbers of hydroxyl groups at positions 3, 5, 14, and 16, and these may be further substituted. For structure, see steroids.
(05 Mar 2000)
bufenolides (one double bond) (05 Mar 2000)
carbon-carbon double bond isomerases <enzyme> Enzymes that catalyze the shifting of a carbon-carbon double bond from one position to another within the same molecule.
Registry number: EC 5.3.3
(12 Dec 1998)
RNA, double-stranded RNA consisting of two strands as opposed to the more prevalent single-stranded RNA. most of the double-stranded segments are formed from transcription of DNA by intramolecular base-pairing of inverted complementary sequences separated by a single-stranded loop. Some double-stranded segments of RNA are normal in all organisms.
(12 Dec 1998)
conjugated double bonds Two or more double bond separated by each single bond.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • double-o
    ¾ö¹ÐÇÑ °Ë»ç
  • double-ripper
    º¾½½·¹ÀÌ
  • double-runner
    º¾½½·¹ÀÌ
  • Double Summer Time
    ÀÌÁß ¼­¸ÓŸÀÓ(Ç¥Áؽ𣺸´Ù 2½Ã°£ ºü¸§)
  • Double Ten
    ½Ö½ÊÀý(Áß±¹ °Ç±¹ ±â³äÀÏ,10¿ù 10ÀÏ)
  • daily double
    (°æ¸¶¿¡¼­)º¹½Â½Ä;2¿¬½Â;µÎ¹ø °è¼ÓµÈ ¼º°ø
  • double
    2¹èÀÇ;2ÁßÀÇ;½ÖÀÇ;Ç¥¸®°¡ ÀÖ´Â;°ÅÁþÀÇ;¸ðÈ£ÇÑ;2¹èÇÏ´Ù;°ãÄ¡´Ù;Á¢´Ù;2¹è°¡µÇ´Ù;´Þ¸®´Ù;ÀÏÀ»°âÇÏ´Ù
  • double Dutch
    Åë ¾Ë¾Æ µéÀ» ¼ö ¾ø´Â ¸»
  • double agent
    ÀÌÁß °£Ã¸
  • double ax
    ¾ç³¯ µµ³¢
  • double bar
    (¾Çº¸ÀÇ)°ã¼¼·ÎÁÙ
  • double bass
    =CONTRABASS
  • double bassoon
    ´õºí¹Ù¼ø;ÄÜÆ®¶ó ¹Ù¼ø
  • double bed
    ´õºíº£µå;2Àοë ħ´ë
  • double bill
    ¿µÈ­;¿¬±ØÀÇ 2Æí µ¿½Ã »ó¿µ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á